[English] 日本語

- EMDB-39911: Cryo-EM structure of nanodisc-reconstituted human MRP4 withE1202Q... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Cryo-EM structure of nanodisc-reconstituted human MRP4 withE1202Q mutation (in complex with lapatinib) | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | ATP-binding cassette sub-family C member 4 / Multidrug resistance proteins (MRPs) / multidrug-resistance (MDR) / TRANSPORT PROTEIN / membrane protein | |||||||||
Function / homology | ![]() 15-hydroxyprostaglandin dehydrogenase (NAD+) activity / purine nucleotide transmembrane transporter activity / cAMP transport / guanine nucleotide transmembrane transporter activity / ABC-type bile acid transporter activity / platelet dense granule membrane / platelet degranulation / leukotriene transport / prostaglandin transport / ABC-type glutathione-S-conjugate transporter ...15-hydroxyprostaglandin dehydrogenase (NAD+) activity / purine nucleotide transmembrane transporter activity / cAMP transport / guanine nucleotide transmembrane transporter activity / ABC-type bile acid transporter activity / platelet dense granule membrane / platelet degranulation / leukotriene transport / prostaglandin transport / ABC-type glutathione-S-conjugate transporter / ABC-type glutathione S-conjugate transporter activity / urate transport / glutathione transmembrane transporter activity / prostaglandin transmembrane transporter activity / urate transmembrane transporter activity / ATPase-coupled inorganic anion transmembrane transporter activity / external side of apical plasma membrane / xenobiotic transmembrane transport / prostaglandin secretion / export across plasma membrane / Paracetamol ADME / ABC-type xenobiotic transporter / Translocases; Catalysing the translocation of other compounds; Linked to the hydrolysis of a nucleoside triphosphate / Azathioprine ADME / ABC-type xenobiotic transporter activity / bile acid and bile salt transport / efflux transmembrane transporter activity / xenobiotic transmembrane transporter activity / cilium assembly / ATPase-coupled transmembrane transporter activity / ABC-type transporter activity / transport across blood-brain barrier / xenobiotic metabolic process / ABC-family proteins mediated transport / transmembrane transport / Platelet degranulation / basolateral plasma membrane / apical plasma membrane / intracellular membrane-bounded organelle / nucleolus / Golgi apparatus / ATP hydrolysis activity / ATP binding / membrane / plasma membrane Similarity search - Function | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.28 Å | |||||||||
![]() | Xie Z / Long F | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Structural basis for the reversal of human MRP4-mediated multidrug resistance by lapatinib. Authors: Zhipeng Xie / Jiaxiang Lv / Wei Huang / Zhikun Wu / Rongli Zhu / Zixin Deng / Feng Long / ![]() Abstract: Multidrug resistance proteins (MRPs) are one of the major mechanisms for developing cancer drug resistance. Human MRP4 (hMRP4) plays an important role in various chemotherapy-resistant cancers. Here, ...Multidrug resistance proteins (MRPs) are one of the major mechanisms for developing cancer drug resistance. Human MRP4 (hMRP4) plays an important role in various chemotherapy-resistant cancers. Here, we show hMRP4 mediates the resistance of a broad spectrum of antitumor reagents in the cultured tumor cells, among which the cell resistance to vincristine and 5-fluorouracil is rescued by supplementing a tyrosinase inhibitor, lapatinib. The cryoelectron microscopy (cryo-EM) structures of hMRP4 in the substrate- or inhibitor-bound form are determined. Although lapatinib shares partial binding sites with vincristine and 5-fluorouracil using a similar set of crucial residues located in the central cavity of hMRP4, the high binding affinity of lapatinib and its unique binding mode with transmembrane helices TM2 and TM12 inside the pathway tunnel prohibit hMRP4 from structural transition between intermediate states during drug translocation. This study provides mechanistic insights into the therapeutical potential of lapatinib in combating hMRP4-mediated MDR. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 52.7 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 17.2 KB 17.2 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 8.4 KB | Display | ![]() |
Images | ![]() | 43.3 KB | ||
Masks | ![]() | 64 MB | ![]() | |
Filedesc metadata | ![]() | 6.9 KB | ||
Others | ![]() ![]() | 59.4 MB 59.4 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 8zbuMC ![]() 8zbsC ![]() 8zbtC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.84 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Mask #1
File | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #2
File | emd_39911_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_39911_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : Cryo-EM structure of nanodisc-reconstituted human MRP4 withE1202Q...
Entire | Name: Cryo-EM structure of nanodisc-reconstituted human MRP4 withE1202Q mutation (in complex with lapatinib) |
---|---|
Components |
|
-Supramolecule #1: Cryo-EM structure of nanodisc-reconstituted human MRP4 withE1202Q...
Supramolecule | Name: Cryo-EM structure of nanodisc-reconstituted human MRP4 withE1202Q mutation (in complex with lapatinib) type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: ![]() |
-Macromolecule #1: ATP-binding cassette sub-family C member 4
Macromolecule | Name: ATP-binding cassette sub-family C member 4 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO EC number: Translocases; Catalysing the translocation of other compounds; Linked to the hydrolysis of a nucleoside triphosphate |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 152.202562 KDa |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: MHHHHHHHHH HMLPVYQEVK PNPLQDANLC SRVFFWWLNP LFKIGHKRRL EEDDMYSVLP EDRSQHLGEE LQGFWDKEVL RAENDAQKP SLTRAIIKCY WKSYLVLGIF TLIEESAKVI QPIFLGKIIN YFENYDPMDS VALNTAYAYA TVLTFCTLIL A ILHHLYFY ...String: MHHHHHHHHH HMLPVYQEVK PNPLQDANLC SRVFFWWLNP LFKIGHKRRL EEDDMYSVLP EDRSQHLGEE LQGFWDKEVL RAENDAQKP SLTRAIIKCY WKSYLVLGIF TLIEESAKVI QPIFLGKIIN YFENYDPMDS VALNTAYAYA TVLTFCTLIL A ILHHLYFY HVQCAGMRLR VAMCHMIYRK ALRLSNMAMG KTTTGQIVNL LSNDVNKFDQ VTVFLHFLWA GPLQAIAVTA LL WMEIGIS CLAGMAVLII LLPLQSCFGK LFSSLRSKTA TFTDARIRTM NEVITGIRII KMYAWEKSFS NLITNLRKKE ISK ILRSSC LRGMNLASFF SASKIIVFVT FTTYVLLGSV ITASRVFVAV TLYGAVRLTV TLFFPSAIER VSEAIVSIRR IQTF LLLDE ISQRNRQLPS DGKKMVHVQD FTAFWDKASE TPTLQGLSFT VRPGELLAVV GPVGAGKSSL LSAVLGELAP SHGLV SVHG RIAYVSQQPW VFSGTLRSNI LFGKKYEKER YEKVIKACAL KKDLQLLEDG DLTVIGDRGT TLSGGQKARV NLARAV YQD ADIYLLDDPL SAVDAEVSRH LFELCICQIL HEKITILVTH QLQYLKAASQ ILILKDGKMV QKGTYTEFLK SGIDFGS LL KKDNEESEQP PVPGTPTLRN RTFSESSVWS QQSSRPSLKD GALESQDTEN VPVTLSEENR SEGKVGFQAY KNYFRAGA H WIVFIFLILL NTAAQVAYVL QDWWLSYWAN KQSMLNVTVN GGGNVTEKLD LNWYLGIYSG LTVATVLFGI ARSLLVFYV LVNSSQTLHN KMFESILKAP VLFFDRNPIG RILNRFSKDI GHLDDLLPLT FLDFIQTLLQ VVGVVSVAVA VIPWIAIPLV PLGIIFIFL RRYFLETSRD VKRLESTTRS PVFSHLSSSL QGLWTIRAYK AEERCQELFD AHQDLHSEAW FLFLTTSRWF A VRLDAICA MFVIIVAFGS LILAKTLDAG QVGLALSYAL TLMGMFQWCV RQSAEVENMM ISVERVIEYT DLEKEAPWEY QK RPPPAWP HEGVIIFDNV NFMYSPGGPL VLKHLTALIK SQEKVGIVGR TGAGKSSLIS ALFRLSEPEG KIWIDKILTT EIG LHDLRK KMSIIPQEPV LFTGTMRKNL DPFNEHTDEE LWNALQEVQL KETIEDLPGK MDTELAESGS NFSVGQRQLV CLAR AILRK NQILIIDQAT ANVDPRTDEL IQKKIREKFA HCTVLTIAHR LNTIIDSDKI MVLDSGRLKE YDEPYVLLQN KESLF YKMV QQLGKAEAAA LTETAKQVYF KRNYPHIGHT DHMVTNTSNG QPSTLTIFET ALDYKDDDDK UniProtKB: ATP-binding cassette sub-family C member 4 |
-Macromolecule #2: N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFO...
Macromolecule | Name: N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE type: ligand / ID: 2 / Number of copies: 1 / Formula: FMM |
---|---|
Molecular weight | Theoretical: 581.058 Da |
Chemical component information | ![]() ChemComp-FMM: |
-Macromolecule #3: MAGNESIUM ION
Macromolecule | Name: MAGNESIUM ION / type: ligand / ID: 3 / Number of copies: 2 / Formula: MG |
---|---|
Molecular weight | Theoretical: 24.305 Da |
-Macromolecule #4: ADENOSINE-5'-TRIPHOSPHATE
Macromolecule | Name: ADENOSINE-5'-TRIPHOSPHATE / type: ligand / ID: 4 / Number of copies: 2 / Formula: ATP |
---|---|
Molecular weight | Theoretical: 507.181 Da |
Chemical component information | ![]() ChemComp-ATP: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 3 mg/mL |
---|---|
Buffer | pH: 8 |
Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 50 sec. |
Vitrification | Cryogen name: ETHANE / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Software | Name: EPU (ver. Version 3.2.0.4776REL) |
Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 50.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model | Chain - Source name: AlphaFold / Chain - Initial model type: in silico model |
---|---|
Output model | ![]() PDB-8zbu: |